Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
GTP-binding protein 8 (GTPBP8) is a nuclear-encoded GTPase localized to the mitochondrial matrix, peripherally associated with the inner mitochondrial membrane[2]. It plays a critical role in the late-stage assembly of the mitochondrial ribosome large subunit (mt-LSU), interacting specifically with the mitochondrial 16S rRNA, and is essential for proper mitoribosome biogenesis[1][2][3]. Loss of GTPBP8 results in accumulation of assembly intermediates, disrupted formation of functional monosomes, impaired mitochondrial translation, and a marked defect in oxidative phosphorylation[1][2][6]. While vital for mitochondrial gene expression and cellular energy metabolism, GTPBP8 is not currently considered a therapeutic drug target, nor are there known drugs, biomarkers, or established safety concerns directly associated with this protein[3][5]. Its dysfunction could theoretically contribute to human mitochondrial disorders, but concrete links to specific diseases are still under investigation[4].
Not applicable; no known drugs target GTPBP8
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on GTP-binding protein 8 (GTPBP8).